A Chinese study involving NIPS data from almost two million pregnant women found that a new bioinformatic approach improves the detection of cancer.
Both teams had sequencing data generated at BGI and said that going forward, it would be important to validate the technology outside of BGI.
Startup AiLife Diagnostics is contributing its NGS analysis, interpretation, and reporting pipelines to BGI's $600 DNBseq WGS assay.
The suit alleges that BGI's sequencing products and reagents infringe a European patent held by Illumina.
Using BGI's sequencing technology, the firms plan to commercialize Natera's Signatera test in China and to develop reproductive health tests in "select markets."
At the AGBT conference, MGI Tech showcased its technologies, while a Sanger Institute researcher presented results from a comparison between BGI and Illumina data.
The Shenzhen, China-based BGI subsidiary plans to expand its business to the United Arab Emirates, Qatar, Saudi Arabia, and other countries.
The effort, led by BGI-Shenzen researchers, could help further plant sequencing studies and inform upcoming large-scale plant sequencing plans.
CNGB was founded by the Chinese government and BGI to collect genomics technologies and resources, and promote their use by the research community.
The chief executive of the National Health Service in England is to call for tumor-agnostic drugs to be "fast-tracked," according to the Times.
Researchers in Australia are sequencing the Wollemi pine tree to try to protect it from extinction, Australia's ABC News reports.
Computerworld ranks Illumina as one of the top midsize organizations to work at in IT.
In Genome Research this week: links between biological aging and mutations affecting epigenetic regulators; long-read sequencing-based strategy to map chromatin accessibility; and more.